Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis

In this model of HR+ mammary carcinogenesis, RT to the primary tumor ameliorates overall survival (to an extent based on dose and fractionation). Increasing local control through RT alone or RT plus immunotherapy beyond a hitherto undefined threshold, however, does not necessarily inhibit the development of subsequent nonirradiated neoplasms and hence does not necessarily provide extra overall survival benefits.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2024-12-10
DOI
https://doi.org/10.1093/jnci/djae329
Citations
9
Primary Topic
Cancer, Stress, Anesthesia, and Immune Response
Type
article
Field-Weighted Citation Impact
3.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis

Aitziber Buqué, Manuel Beltrán‐Visiedo, Silvia C. Formenti, Tania Pannellini et al.
9 citations
JNCI Journal of the National Cancer Institute
Cancer, Stress, Anesthesia, and Immune Response
3.47
article

Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis

Aitziber Buqué, Manuel Beltrán‐Visiedo, Silvia C. Formenti, Tania Pannellini, Andrea Guarracino, Bhavneet Bhinder, Xi Kathy Zhou, Giulia Petroni, Brady Rippon, Carlos Jiménez‐Cortegana, Jitka Fučíková, Sandra Demaria, Cristina Iribarren, Ruth Soler-Agesta, Olivier Elemento, Claudia Galassi, Lorenzo Galluzzi, Norma Bloy, Michal Hensler, Takahiro Yamazaki, Ai Sato
article en
9 citations

Abstract

In this model of HR+ mammary carcinogenesis, RT to the primary tumor ameliorates overall survival (to an extent based on dose and fractionation). Increasing local control through RT alone or RT plus immunotherapy beyond a hitherto undefined threshold, however, does not necessarily inhibit the development of subsequent nonirradiated neoplasms and hence does not necessarily provide extra overall survival benefits.

JNCI Journal of the National Cancer InstituteVol. 117(5)
Fox Chase Cancer Center (US), University of Tennessee Health Science Center (US), Cornell University (US), Charles University (CZ), Universidad de Zaragoza (ES), Lander Institute (IL), University Hospital in Motol (CZ), CancerCare (US), Sotio (Czechia) (CZ), Human Technopole (IT), Weill Cornell Medicine (US), University of Florence (IT)
U.S. Department of Defense, Leukemia and Lymphoma Society, National Institutes of Health, Weill Cornell Medical College, Stand Up To Cancer, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 6%
Cancer, Stress, Anesthesia, and Immune Response
3.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.